PrEP Assistance Program Act
Summary
What This Bill Does
The PrEP Assistance Program Act directs HHS, through CDC and HRSA, to establish PrEP grants within one year for eligible entities such as states, local governments, Indian Tribal governments, FQHCs, rural health clinics, community-based organizations, hospital-based clinics, and university-based clinics. Grants are capped at $10 million, prioritize entities serving communities with disproportionately high HIV incidence or using innovative models like vending machines, pop-up clinics, and peer-led interventions, and may pay for clinic and lab fees, telehealth visits, PrEP medication, blood and urine testing, STI testing, adherence counseling, outreach, peer navigation, case management, transportation, and mental-health services. The bill also creates a HRSA reimbursement program and a PrEP Pass for uninsured individuals, with provider claims paid at HHS-set rates and no cost-sharing for covered prevention services.
Who Benefits and How
Uninsured people at risk of HIV, rural residents, high-incidence communities, and demographic groups with elevated HIV risk benefit from free PrEP medication and wraparound prevention services. FQHCs, rural health clinics, community-based organizations, hospitals, university clinics, states, local governments, and Indian Tribal governments benefit from grant funding and a provider reimbursement path. PrEP drug manufacturers, labs, and prevention providers may see more paid utilization.
Who Bears the Burden and How
HHS, CDC, and HRSA must build grant rules, provider registration, PrEP Pass technology, provider payment amounts, eligible-expense lists, public reports, and disaggregated impact data. Most grantees must contribute a 10 percent match unless they are tribal governments or receive a waiver. Program-registered providers must agree not to bill uninsured individuals for reimbursed PrEP items and services. Federal taxpayers fund the $400 million annual authorization for fiscal years 2027 through 2031 and any reimbursements subject to appropriations.
Key Provisions
- Creates CDC-HRSA PrEP grants capped at $10 million per eligible entity for states, localities, tribes, FQHCs, rural clinics, community organizations, hospitals, and university clinics.
- Authorizes grant spending for PrEP medication, labs, telehealth, STI testing, counseling, outreach, peer navigation, case management, transportation, and mental-health support.
- Requires covered PrEP items and services to be free to individuals served by grant-supported programs.
- Creates a HRSA reimbursement program and PrEP Pass so uninsured individuals can obtain specified HIV prevention services at no cost.
- Authorizes $400 million annually for fiscal years 2027 through 2031 and requires public impact reports with race, gender identity, age, and geography data.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
Creates HHS grant and reimbursement programs to make HIV pre-exposure prophylaxis medications, labs, counseling, and related prevention services available at no cost, especially for uninsured and high-risk communities.
Key Policy Areas
Healthcare, Pharmaceuticals, Social Services
Primary Purpose
Creates HHS grant and reimbursement programs to make HIV pre-exposure prophylaxis medications, labs, counseling, and related prevention services available at no cost, especially for uninsured and high-risk communities.
Policy Domains
Substantive provisions
Identified Gains
- Uninsured people at risk of HIV
- FQHCs
- Rural health clinics
- Community based organizations
- Indian Tribal governments
- PrEP drug manufacturers
Identified Costs
- HHS
- CDC
- HRSA
- Grant recipients
- Program registered providers
- Federal taxpayers
Sponsors
Legislative Progress
In CommitteeReferred to the House Committee on Energy and Commerce.
Introduced in House
Mrs. Watson Coleman (for herself, Mr. Carson, Ms. Waters, Ms. …
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
FQHCs, Grant recipients, HHS
Positive-direction: FQHCs, Program registered providers, Uninsured people at risk of HIV
Negative-direction: Grant recipients, HHS, HRSA
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "cdc"
- → Centers for Disease Control and Prevention
- "hrsa"
- → Health Resources and Services Administration
- "secretary"
- → HHS Secretary
Key Definitions
Terms defined in this bill
FDA-approved HIV-prevention drugs including PrEP, administrative fees, and CDC-recommended laboratory or diagnostic procedures associated with PrEP use.
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology